Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease.
Single-center Experience With Upadacitinib for Adolescents With Refractory Inflammatory Bowel Disease. Inflamm Bowel Dis. 2024 11 04; 30(11):2057-2063.